Existing technologies allow isolating antigen-specific monoclonal antibodies (mAbs) from B cells. We devised a direct approach to isolate mAbs with predetermined conformational epitope specificity, using epitope mimetics (mimotopes) that reflect the three-dimensional structure of given antigen subdomains. We performed differential biopanning using bacteriophages encoding random peptide libraries and polyclonal antibodies (Abs) that had been affinity-purified with either native or denatured antigen. This strategy yielded conformational mimotopes. We then generated mimotope-fluorescent protein fusions, which were used as baits to isolate single memory B cells from rhesus monkeys (RMs). To amplify RM immunoglobulin variable regions, we develop...
Monoclonal antibodies that effectively neutralize HIV-1 have been widely sought, yet few have been i...
The production of broadly neutralizing antibodies (bNAbs) is a major goal in the development of an H...
HIV-1 mucosal transmission begins with virus or virus-infected cells moving through mucus across muc...
<div><p>Existing technologies allow isolating antigen-specific monoclonal antibodies (mAbs) from B c...
Existing technologies allow isolating antigen-specific monoclonal antibodies (mAbs) from B cells. We...
We describe three recombinant engineered antibodies against three recombinant epitope tags, construc...
Two to three years after infection, a fraction of HIV-1–infected individuals develop serologic activ...
Isolation and production of therapeutic human monoclonal antibodies (mAbs) traditionally utilizes a ...
Thesis (Ph.D.)--University of Washington, 2023Emerging viruses and antibiotic-resistant bacteria are...
Cytotoxic T lymphocytes (CTL) protect against viruses including HIV-1. To avoid viral escape mutants...
Characterization of the epitopes on antigen recognized by monoclonal antibodies (mAb) is useful for ...
Despite considerable interest in the isolation of mAbs with potent neutralization activity against p...
Background The isolation of human monoclonal antibodies (mAbs) that neutralize a broad spectrum of p...
Human antibody responses are established by the generation of combinatorial sequence diversity in an...
BACKGROUND: The isolation of human monoclonal antibodies (mAbs) that neutralize a broad spectrum of ...
Monoclonal antibodies that effectively neutralize HIV-1 have been widely sought, yet few have been i...
The production of broadly neutralizing antibodies (bNAbs) is a major goal in the development of an H...
HIV-1 mucosal transmission begins with virus or virus-infected cells moving through mucus across muc...
<div><p>Existing technologies allow isolating antigen-specific monoclonal antibodies (mAbs) from B c...
Existing technologies allow isolating antigen-specific monoclonal antibodies (mAbs) from B cells. We...
We describe three recombinant engineered antibodies against three recombinant epitope tags, construc...
Two to three years after infection, a fraction of HIV-1–infected individuals develop serologic activ...
Isolation and production of therapeutic human monoclonal antibodies (mAbs) traditionally utilizes a ...
Thesis (Ph.D.)--University of Washington, 2023Emerging viruses and antibiotic-resistant bacteria are...
Cytotoxic T lymphocytes (CTL) protect against viruses including HIV-1. To avoid viral escape mutants...
Characterization of the epitopes on antigen recognized by monoclonal antibodies (mAb) is useful for ...
Despite considerable interest in the isolation of mAbs with potent neutralization activity against p...
Background The isolation of human monoclonal antibodies (mAbs) that neutralize a broad spectrum of p...
Human antibody responses are established by the generation of combinatorial sequence diversity in an...
BACKGROUND: The isolation of human monoclonal antibodies (mAbs) that neutralize a broad spectrum of ...
Monoclonal antibodies that effectively neutralize HIV-1 have been widely sought, yet few have been i...
The production of broadly neutralizing antibodies (bNAbs) is a major goal in the development of an H...
HIV-1 mucosal transmission begins with virus or virus-infected cells moving through mucus across muc...